SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-001022
Filing Date
2021-01-04
Accepted
2021-01-04 16:35:56
Documents
6
Effectiveness Date
2021-01-04

Document Format Files

Seq Description Document Type Size
1 S-8 d81888ds8.htm S-8 69763
2 EX-5.1 d81888dex51.htm EX-5.1 4687
3 EX-23.1 d81888dex231.htm EX-23.1 1854
4 EX-23.2 d81888dex232.htm EX-23.2 2043
5 EX-99.3 d81888dex993.htm EX-99.3 44096
6 GRAPHIC g81888g96j95.jpg GRAPHIC 3241
  Complete submission text file 0001193125-21-001022.txt   128183
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-251881 | Film No.: 21502218
SIC: 2834 Pharmaceutical Preparations